Metformin effect on urethane-induced tumorigenesis in mice

Voprosy Onkologii

Volumn 58, Issue 4, 2012, Pages 549-553

  Popovich, I G ^a   Piskunova, T S ^a   Tyndyk, M L ^a   Anikin, I V ^a   Zabezhinski, M A ^a   Anisimov, V N ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; THYMUS LYMPHOMA;

ADENOMA; ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; LUNG NEOPLASMS; LYMPHOMA; MALE; METFORMIN; MICE; THYMUS NEOPLASMS; URETHANE;

EID: 84875853086     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Alexandrov V.A., Anisimov V.N., Belous N.M. et al. The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats // Carcinogenesis. - 1980. - Vol. 1. - P. 975-978.
2. Algire C., Amrein L., Zakikhan M. et al. Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and its associated with reduced expression of fatty acid synthase // Endocrine-related Cancer. - 2010. - Vol. 17. - P. 351-360.
3. Algire C., Moiseeva O., Deschenes-Simard X. et al. Metformin reduces endogenous reactive oxygen species and associated DNA damage // Cancer Prev. Res. - 2012 [Epub ahead of print].
4. Alimova I.N., Liu B., Fan Z. et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro // Cell Cycle. - 2009. - Vol. 8. - P. 909-915.
5. Anisimov V.N. Metformin for aging and cancer prevention // Aging (Albany NY). - 2010. - Vol. 2. - P. 760-774.
6. Anisimov V.N., Osipova G.Yu. Two-step carcinogenesis by neonatal exposure to 5-bromo-2′-deoxyuridine and subsequent administration of urethan in BALB/c mice // Cancer Lett. - 1992. - Vol. 64. - P. 75-82.
7. Anisimov V.N., Berstein L.M., Egormin P.A. et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice // Exp. Gerontol. - 2005. - Vol. 40. - P. 685-693.
8. Anisimov V.N., Berstein L.M., Egormin P.A. et al. Metformin slows down aging and extends life span of female SHR mice // Cell Cycle. - 2008. - Vol. 7. - P. 2769-2773.
9. Anisimov V.N., Semenchenko A.V., Yashin A.I. Insulin and longevity: antidiabetic biguanides as geroprotectors // Biogerontology. - 2003. - Vol. 4. - P. 297-307.
10. Berstein L.M. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer // Cancer Lett. - 2005. - Vol. 24. - P. 203-212.
11. Bojkova B., Orendas P., Garajlova M. et al. Metformin in chemically-induced mammary carcinogenesis in rats // Neoplasma. - 2009. - Vol. 56. - P. 269-274.
12. Caraci F., Chisari M., Frasca G. et al. Effects of phenformin on the proliferation of human tumor cell lines // Life Sci. - 2003. - Vol. 74. - P. 643-650.
13. Currie C.J., Poole C.D., Gale E.A.M. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes // Diabetologia. - 2009. - Vol. 52. - P. 1766-1777.
14. Dilman V.M. Development, Aging and Disease. A New Rationale for an Intervention. - Chur: Harwood Academic Publ., 1994. - 387 p.
15. Dilman V.M., Anisimov V.N. Effect of treatment with phenformin, diphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice // Gerontology. - 1980. - Vol. 26. - P. 241-245.
16. Dilman V.M., Anisimov V.N. Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin) // Cancer Lett. - 1979. - Vol. 7. - P. 357-361.
17. Erdemoglu E., Güney M., Giray S.G. et al. Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia // Europ. J. Obstet. Gynecol. Reprod. Biol. - 2009. - Vol. 145. - P. 195-199.
18. Evans J.M.M., Donnelly L.A., Emslie-Smith A.M. et al. Metformin and reduced risk of cancer in diabetic patients // Brit. Med. J. - 2005. - Vol. 330. - P. 1304-1305.
19. Facchini F.S., Hua N.W., Reaven G.M., Stoohs R.A. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? // Free Radic. Biol. Med. - 2000. - Vol. 29. - P. 1302-1306.
20. Gargiulo P., Caccese D., Pignatelli P. et al. Metformin decreases platelet superoxide anion production in diabetic patients// Diabetes Metab. Res. Rev. - 2002. - Vol. 18. - P. 156-159.
21. Hosono K., Endo H., Takahashi H. et al. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by AMP-activating protein kinase // Mol. Carcinogenesis. - 2010. - Vol. 49. - P. 662-671.
22. Hwang Y.P., Jeong H.G. Metformin blocks migration and invasion of tumour cells by inhibition of matrix mettalloproteinase-9 activation through a calcium and protein kinase C alpha-dependent pathway: phorbol-12-myristate-acetate- induced extracellular signal-regulated kinase/activator protein-1 // Brit. J. Pharmacol. - 2010. - Vol. 160. - P. 1195-1211.
23. Lea M.A., Chako J., Bolikal S. et al. Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin // Anticancer Res. - 2011. - Vol. 31. - P. 421-426.
24. Martin-Castillo B., Vazquez-Martin A., Oliveras-Ferraros C., Menendez J.A. Metformin and cancer. Doses, mechanisms and the dandelion and hormetic phenomena // Cell Cycle. - 2010. - Vol. 9. - P. 1057-1064.
25. Memmott R.M., Mercado J.R., Maier C.R. et al. Metformin prevents tobacco carcinogen-induced lung tumorigenesis // Cancer Prev. Res. - 2010. - Vol. 3. - P. 1066-1076.
26. Muntoni S. Metformin and fatty acids // Diabetes Care. - 1999. - Vol. 22. - R 179-180.
27. Parkin D.M. Bray F.I., Deseva S.S. Cancer burden in the year 2000. The global picture // Europ. J. Cancer. - 2001. - Vol. 37. - P. S4-S66.
28. 1,induces mTOR inhibition and cell-cycle arrest through REDD1 // Cancer Res. - 2011. - Vol. 71. - P. 4366-4372.
29. Sakano K., Oikawa S., Hiraku Y., Kawanishi S. Metabolism of carcinogenic urethane to nitric oxide is involved in oxidative DNA damage // Free Radic. Biol. Med. - 2002. - Vol. 33. - P. 703-714.
30. Schneider M.B., Matsuzaki H., Harorah J. et al. Prevention of pancreatic cancer induction in hamsters by metformin // Gastroenterology. - 2001. - Vol. 120. - P. 1263-1270.
31. Tan B.K., Adva R., Chen J. et al. Metformin treatment exert antiinvasive and antimetastatic effects in human endometrial carcinoma cells // J. Clin. Endocrinol. Metab. - 2011. - Vol. 98. - P. 808-816.
32. nd ed). IARC Sci. Publ. No. 111. - Lyon: IARC, 1993. - 776 p.